AXIM Biotechnologies, Inc. announced that it has entered into a securities purchase agreement with Catalina Valencia for a private placement of 3,861,004 restricted shares at a price of $0.0259 per share for gross proceeds of $100,000.0036 on August 24, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0138 USD | +0.73% | +8.66% | -27.37% |
1st Jan change | Capi. | |
---|---|---|
-27.37% | 3.81M | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- AXIM Stock
- News AXIM Biotechnologies, Inc.
- AXIM Biotechnologies, Inc. announced that it expects to receive $0.1 million in funding